Literature DB >> 12614318

Focal and segmental primary dystonia in north-western Germany--a clinico-genetic study.

S Maniak1, M Sieberer, J Hagenah, C Klein, P Vieregge.   

Abstract

OBJECTIVES: To determine the frequency of familial focal and segmental dystonias in a large patient cohort with primary dystonia from north-western Germany.
MATERIALS AND METHODS: In this study, 130 patients with focal or segmental dystonia were examined and a family history was obtained. Whenever possible, affected relatives were examined (a total of 789 first-degree relatives). Data on disease duration, age at disease onset and age of the patients were investigated by Student's t-test and a segregation analysis was performed by Weinberg's proband method.
RESULTS: Age at onset of disease was significantly later in the blepharospasm group. Only in the writer's cramp group were women outnumbered by men. A positive family history was found in 15 of the 130 index patients (11.5%). None of 102 index patients tested carried the GAG deletion in the DYT1 gene.
CONCLUSIONS: In accordance with previous series our study provides evidence that primary focal dystonia may have a genetic etiology, most probably caused by an autosomal dominant trait with reduced penetrance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614318     DOI: 10.1034/j.1600-0404.2003.01362.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

2.  Novel THAP1 sequence variants in primary dystonia.

Authors:  J Xiao; Y Zhao; R W Bastian; J S Perlmutter; B A Racette; S D Tabbal; M Karimi; R C Paniello; Z K Wszolek; R J Uitti; J A Van Gerpen; D K Simon; D Tarsy; P Hedera; D D Truong; K P Frei; S Dev Batish; A Blitzer; R F Pfeiffer; S Gong; M S LeDoux
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

3.  Late-onset primary dystonia in Zhejiang province of China: a service-based epidemiological study.

Authors:  Li Wang; Yin Chen; Beibei Hu; Xingyue Hu
Journal:  Neurol Sci       Date:  2015-08-26       Impact factor: 3.307

4.  Descriptive epidemiology of cervical dystonia.

Authors:  Giovanni Defazio; Joseph Jankovic; Jennifer L Giel; Spyridon Papapetropoulos
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-11-04

5.  Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice.

Authors:  Fumiaki Yokoi; Huan-Xin Chen; Mai Tu Dang; Chad C Cheetham; Susan L Campbell; Steven N Roper; J David Sweatt; Yuqing Li
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran.

Authors:  Mohammad Hamid; Mohammad Taghi Akbari; Gholam Ali Shahidi; Zahra Zand
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

7.  The environmental epidemiology of primary dystonia.

Authors:  Giovanni Defazio; Angelo F Gigante
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-05-03

8.  Animal models for investigating benign essential blepharospasm.

Authors:  Craig Evinger
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

9.  High-throughput mutational analysis of TOR1A in primary dystonia.

Authors:  Jianfeng Xiao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Andrew Blitzer; Sat Dev Batish; Zbigniew K Wszolek; Ryan J Uitti; Peter Hedera; David K Simon; Daniel Tarsy; Daniel D Truong; Karen P Frei; Ronald F Pfeiffer; Suzhen Gong; Yu Zhao; Mark S LeDoux
Journal:  BMC Med Genet       Date:  2009-03-11       Impact factor: 2.103

10.  Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia.

Authors:  Giovanni Defazio; Giovanni Abbruzzese; Paolo Girlanda; Rocco Liguori; Lucio Santoro; Michele Tinazzi; Alfredo Berardelli
Journal:  J Neurol       Date:  2012-05-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.